Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022048

TRIESENCE (TRIAMCINOLONE ACETONIDE)
40MG/ML (40MG/ML) Marketing Status: Prescription

Active Ingredient: TRIAMCINOLONE ACETONIDE
Proprietary Name: TRIESENCE
Dosage Form; Route of Administration: INJECTABLE; INTRAVITREAL
Strength: 40MG/ML (40MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022048
Product Number: 001
Approval Date: Nov 29, 2007
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English